HL-60 myeloid leukaemia cells acquire immunostimulatory capability upon treatment with retinoic acid: analysis of the responding population and mechanism of cytotoxic lymphocyte ac...

Por Geary, S M, Ashman, L K
Publicado em 1996

Binding of mouse monoclonal antibodies to human leukaemic cells via the Fc receptor: a possible source of 'false positive' reactions in specificity screening.

Por Gadd, S J, Ashman, L K
Publicado em 1983

Specificity of the passive antibody-induced suppression of the humoral immune response of mice to surface antigens on human cells.

Por Gadd, S J, Brogan, M P, Ashman, L K
Publicado em 1985

Probabilistic application of plasma carcinoembryonic antigen assay in cancer patients.

Por Ashman, L K, Ludbrook, J, Marshall, V R
Publicado em 1975

Transmembrane 4 superfamily protein CD151 (PETA-3) associates with beta 1 and alpha IIb beta 3 integrins in haemopoietic cell lines and modulates cell-cell adhesion.

Por Fitter, S, Sincock, P M, Jolliffe, C N, Ashman, L K
Publicado em 1999

Dexamethasone inhibits the development of mast cells from dispersed human fetal liver cells cultured in the presence of recombinant human stem cell factor.

Por Irani, A A, Nilsson, G, Ashman, L K, Schwartz, L B
Publicado em 1995

Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product.

Por Furitsu, T, Tsujimura, T, Tono, T, Ikeda, H, Kitayama, H, Koshimizu, U, Sugahara, H, Butterfield, J H, Ashman, L K, Kanayama, Y
Publicado em 1993

Phenotypic characterization of stem cell factor-dependent human foetal liver-derived mast cells.

Por Nilsson, G, Forsberg, K, Bodger, M P, Ashman, L K, Zsebo, K M, Ishizaka, T, Irani, A M, Schwartz, L B
Publicado em 1993